Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months

By Ibáñez Lourdes   López-bermejo Abel   Díaz Marta   Enríquez Goya   Del Río Luis   De Zegher Francis  

Gynecological Endocrinology, Vol. 26, Iss. 12, 2010-12 ,pp. : 869-873

Informa Healthcare

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment

By Jakubowska Joanna   Bohdanowicz-Pawlak Anna   Milewicz Andrzej   Szymczak Jadwiga   Bednarek-Tupikowska Grazyna   Demissie Marek  

Gynecological Endocrinology, Vol. 24, Iss. 7, 2008-01 ,pp. : 378-384

Informa Healthcare

Access to resources Recommend Favorite

Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin

By Koivunen Riitta M.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2546-2551

Oxford University Press

Access to resources Recommend Favorite